OR56A3
OR56A3 is a gene that encodes a protein in humans. It is also known as olfactory receptor 56A3. Olfactory receptors are proteins that bind odor molecules in the nose, initiating a neural response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes.
Function
The OR56A3 gene is part of the olfactory receptor family, a class of genes that play a crucial role in our sense of smell. These receptors detect odor molecules and send signals to our brain, allowing us to identify and respond to different scents. The OR56A3 gene, like other olfactory receptors, is thought to have a broad ligand profile, meaning it can bind to and detect a wide range of odor molecules.
Structure
The OR56A3 protein is a member of the G protein-coupled receptor 1 family. It is a transmembrane protein, meaning it spans the membrane of cells. The protein has seven transmembrane domains, a characteristic feature of GPCRs. These domains allow the protein to receive signals from outside the cell and transmit them inside the cell.
Expression
The OR56A3 gene is predominantly expressed in the olfactory epithelium, the tissue inside the nose that is responsible for smell. This tissue contains the olfactory receptor neurons, which are the cells that express the olfactory receptors.
Clinical significance
While the specific clinical significance of OR56A3 is not yet fully understood, olfactory receptors in general are being studied for their potential roles in disease. For example, changes in the sense of smell are often among the first symptoms of neurodegenerative diseases like Parkinson's disease and Alzheimer's disease. Understanding the function and regulation of olfactory receptors like OR56A3 could therefore contribute to early detection and treatment strategies for these diseases.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD